The use of probability maps to deal with the uncertainties in prostate cancer delineation

Radiother Oncol. 2010 Feb;94(2):168-72. doi: 10.1016/j.radonc.2009.12.023. Epub 2010 Jan 19.

Abstract

Background and purpose: The use of dynamic contrast-enhanced (DCE) imaging for delineation of prostate tumors requires that decisions are made on a voxel wise basis about the presence of tumor. While the sensitivity and specificity of this technique is high, we propose a probabilistic approach to deal with the intrinsic imaging uncertainty.

Material and methods: Twenty-nine patients with biopsy-proven prostate cancer underwent a DCE-CT exam prior to radiotherapy. From a logistic regression on K(trans) values from healthy and diseased appearing prostate regions we obtained a probability function for the presence of tumor. K(trans) parameter maps were converted into probability maps and a stratification was applied at the 5% and 95% probability level, to identify low-, intermediate-, and high-risk areas for the presence of tumor.

Results: In all patients, regions with high-, intermediate-, and low-risk were identified, with median volume percentages of 7.6%, 40.0%, and 52.1%, respectively. The contiguous areas that resulted from the voxel wise stratification can be interpreted as GTV, high-risk CTV, and CTV.

Conclusions: K(trans) parameter maps from a DCE-CT exam can be converted into probability maps for the presence of tumor. In this way, the intrinsic uncertainty that a voxel contains tumor can be incorporated into the treatment planning process.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Aged
  • Aged, 80 and over
  • Algorithms
  • Biopsy
  • Contrast Media
  • Humans
  • Imaging, Three-Dimensional
  • Iohexol / analogs & derivatives
  • Logistic Models
  • Male
  • Middle Aged
  • Probability
  • Prostatic Neoplasms / diagnostic imaging*
  • Prostatic Neoplasms / pathology
  • Radiographic Image Interpretation, Computer-Assisted
  • Radiotherapy Planning, Computer-Assisted / methods*
  • Tomography, X-Ray Computed*

Substances

  • Contrast Media
  • Iohexol
  • iopromide